Trials / Completed
CompletedNCT02323308
Isolated Anti-HBc Serological Profile in HIV Infected Patients: Immunological, Virological Characteristics and Response to Hepatitis B Vaccination
Study of Immunological, Virological, Serological Characteristics of HIV+ Patients Harboring Isolated Anti-HBc Profile and Response to Hepatitis B Vaccination
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 55 (actual)
- Sponsor
- ANRS, Emerging Infectious Diseases · Other Government
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The aim of study is to describe the clinical, immunological, serological, virological and therapeutic characteristics of HIV+ patients harboring isolated anti-HBc profile and to assess the response to vaccination in these patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | blood sampling |
Timeline
- Start date
- 2010-12-01
- Primary completion
- 2014-06-01
- Completion
- 2014-06-01
- First posted
- 2014-12-23
- Last updated
- 2014-12-23
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02323308. Inclusion in this directory is not an endorsement.